Sysmex Corporation (TYO:6869)

Japan flag Japan · Delayed Price · Currency is JPY
2,444.00
-13.00 (-0.53%)
May 28, 2025, 3:30 PM JST
-8.34%
Market Cap 1.51T
Revenue (ttm) 508.64B
Net Income (ttm) 53.67B
Shares Out 619.07M
EPS (ttm) 86.05
PE Ratio 28.40
Forward PE 24.48
Dividend 36.00 (1.47%)
Ex-Dividend Date Mar 28, 2025
Volume 1,641,100
Average Volume 1,422,975
Open 2,456.50
Previous Close 2,457.00
Day's Range 2,442.00 - 2,476.50
52-Week Range 2,138.00 - 3,236.00
Beta 0.86
RSI 36.12
Earnings Date May 14, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;... [Read more]

Sector Healthcare
Founded 1968
Employees 10,042
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 6869
Full Company Profile

Financial Performance

In 2024, Sysmex's revenue was 508.64 billion, an increase of 10.21% compared to the previous year's 461.51 billion. Earnings were 53.67 billion, an increase of 8.12%.

Financial Statements

News

Sysmex reports 9M results

3 months ago - Seeking Alpha

Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B

Sysmex (SSMXY) reports a strong 1H performance with GAAP EPS of ¥41.70 and revenue of ¥242.48B, an impressive 14.0% increase year-over-year.

7 months ago - Seeking Alpha